Support Alert

Class 2 medicines recall: Rifadin 600mg Infusion

06 May 2016

Class 2 medicines recall (action within 48 hours): Rifadin 600mg Infusion (Aventis Pharma Limited trading as Sanofi)

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a class 2 medicines recall for a specified batch of Rifadin 600mg Infusion manufactured by Aventis Pharma Limited trading as Sanofi. This is because an investigation indicated that it was contaminated with chilled water.

Further details of the affected batch and action to take are available on the MHRA website